The relationship between acute coronary syndrome and stress hyperglycemia

Experimental and Clinical Endocrinology and Diabetes

Volumn 122, Issue 4, 2014, Pages 222-226

  Ayhan, H ^a   Durmaz, T ^a   Keles T ^a   Bayram, N A ^b   Bilen, E ^b   Akcay M ^a   Ersoy, R ^b   Bozkurt, E ^a  

^a YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

acute coronary syndromes; extent of coronary artery disease; stress hyperglycemia

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; C REACTIVE PROTEIN; CREATINE KINASE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOGRAPH; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; GENSINI SCORE; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PHOTOMETER; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; STRESS HYPERGLYCEMIA; AGED; BLOOD; COMPLICATION; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PHYSIOLOGICAL STRESS; PHYSIOLOGY; PROSPECTIVE STUDY;

ACUTE CORONARY SYNDROME; AGED; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CREATINE KINASE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; STRESS, PHYSIOLOGICAL; TROPONIN I;

EID: 84899498462     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0034-1367002     Document Type: Article

References (29)

1. McCowen K. C., Malhotra A., Bistrian B. R. Stress-induced hyperglycemia. Crit Care Clin: 2001; 17 107 124 (Pubitemid 32163181)
2. Katz L. E., DeLeon D. D., Zhao H. et al. Free and total insulin-like growth factor (IGF)-I levels decline during fasting: relationships with insulin and IGF-binding protein-1. J Clin Endocrinol Metab: 2002; 87 2978 2983 (Pubitemid 34655373)
3. Bolk J., van der Ploeg T., Cornel J. H. et al. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol. 2001; 79 207 214
4. Kosiborod M., Rathore S. S., Inzucchi S. E. et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation: 2005; 111 3078 3086 (Pubitemid 40847785)
5. Capes S. E., Hunt D., Malmberg K. et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet: 2000; 355 773 778 (Pubitemid 30128815)
6. Ertorer M. E., Haydardedeoglu F. E., Erol T. et al. Newly diagnosed hyperglycemia and stress hyperglycemia in a coronary intensive care unit. Diabetes Res Clin Pract: 2010; 90 8 14
7. Ceriello A. Acute hyperglycaemia: a new' risk factor during myocardial infarction. Eur Heart J: 2005; 26 328 331 (Pubitemid 40283091)
8. Cheung N. W., Wong V. W., McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care: 2006; 29 765 770 (Pubitemid 44115291)
9. Malmberg K., Norhammar A., Wedel H. et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation: 1999; 99 2626 2632 (Pubitemid 29237448)
10. Mellbin L. G., Malmberg K., Norhammar A. et al. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Eur Heart J: 2008; 29 166 176
11. Diaz R., Goyal A., Mehta S. R. et al. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA: 2007; 298 2399 2405 (Pubitemid 350190781)
12. G.G G editor Coronary arteriography. 1975 ed. NY, 261. Futura publishing Co.: 1975
13. Norhammar A., Tenerz A., Nilsson G. et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet: 2002; 359 2140 2144 (Pubitemid 34694020)
14. Rouleau J. L., Packer M., Moye L. et al. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol: 1994; 24 583 591 (Pubitemid 24295729)
15. Nian M., Lee P., Khaper N. et al. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res: 2004; 94 1543 1553 (Pubitemid 38856961)
16. Jones R. L., Peterson C. M. Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon. J Clin Invest: 1979; 63 485 493 (Pubitemid 9130212)
17. Ceriello A., Giugliano D., Quatraro A. et al. Hyperglycemia may determine fibrinopeptide A plasma level increase in humans. Metabolism: 1989; 38 1162 1163 (Pubitemid 20015488)
18. Ceriello A., Giugliano D., Quatraro A. et al. Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetologia: 1988; 31 889 891 (Pubitemid 19054758)
19. Giugliano D., Marfella R., Coppola L. et al. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation: 1997; 95 1783 1790 (Pubitemid 27164394)
20. Williams S. B., Goldfine A. B., Timimi F. K. et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation: 1998; 97 1695 1701 (Pubitemid 28211418)
21. Marfella R., Di Filippo C., Portoghese M. et al. Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. J Am Coll Cardiol: 2009; 53 1425 1436
22. Dandona P., Aljada A., Chaudhuri A. et al. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation: 2005; 111 1448 1454 (Pubitemid 40396812)
23. Garadah T. S., Kassab S., Al-Shboul Q. M. et al. The threshold of admission glycemia as a predictor of adverse events in diabetic and non-diabetic patients with acute coronary syndrome. Clin Med Cardiol: 2009; 3 29 36
24. de Mulder M., Oemrawsingh R. M., Stam F. et al. Current management of hyperglycemia in acute coronary syndromes: a national Dutch survey. Crit Pathw Cardiol: 2009; 8 66 70 quiz 1
25. Kociol R. D., Peterson E. D., Hammill B. G. et al. National survey of hospital strategies to reduce heart failure readmissions: findings from the Get With the Guidelines-Heart Failure registry. Circ Heart Fail: 2012; 5 680 687
26. de Mulder M., Umans V. A., Stam F. et al. Intensive management of hyperglycaemia in acute coronary syndromes. Study design and rationale of the BIOMArCS 2 glucose trial. Diabet Med: 2011; 28 1168 1175
27. Iwakura K., Ito H., Ikushima M. et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol: 2003; 41 1 7 (Pubitemid 36044395)
28. Kosiborod M., Inzucchi S. E., Krumholz H. M. et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation: 2008; 117 1018 1027
29. Pinto D. S., Skolnick A. H., Kirtane A. J. et al. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol: 2005; 46 178 180 (Pubitemid 40905149)